← Open Payments lookup

KATIE ZILIAK: Open Payments

NPI 1558747097 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,920 in 48 payments from 13 companies in 2025. Trend: 2023 $1,595 · 2024 $1,726 · 2025 $1,920

Food & beverage: $1,920
CompanyPaymentsAmount
AOP Health US, LLC1$600
PFIZER INC.13$351
Alexion Pharmaceuticals, Inc.9$222
Inspire Medical Systems, Inc.1$180
Aimmune Therapeutics, Inc.5$127
ABBVIE INC.3$93
Ferring Pharmaceuticals Inc.3$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$77
VERTEX PHARMACEUTICALS INCORPORATED3$67
Boehringer Ingelheim Pharmaceuticals, Inc.3$52

Products named: Rapiblyk, VYNDAQEL, ULTOMIRIS, INSPIRE, VOWST, DALVANCE, REBYOTA, XIFAXAN.

Industry payments across TX — which companies pay providers there.